DrugPatentWatch Database Preview
Ani Pharms Inc Company Profile
What is the competitive landscape for ANI PHARMS INC, and what generic alternatives to ANI PHARMS INC drugs are available?
ANI PHARMS INC has one hundred and fifty-five approved drugs.
There is one US patent protecting ANI PHARMS INC drugs.
Summary for Ani Pharms Inc
| US Patents: | 1 |
| Tradenames: | 90 |
| Ingredients: | 86 |
| NDAs: | 155 |
Drugs and US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | TABLET;ORAL | 076550-001 | Apr 23, 2004 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Ani Pharms Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077725-004 | Jul 31, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Ani Pharms Inc | ACETOHEXAMIDE | acetohexamide | TABLET;ORAL | 070869-001 | Feb 9, 1987 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 087781-001 | Jun 8, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | ARIMIDEX | anastrozole | TABLET;ORAL | 020541-001 | Dec 27, 1995 | RE36617*PED | ➤ Sign Up |
| Ani Pharms Inc | CASODEX | bicalutamide | TABLET;ORAL | 020498-001 | Oct 4, 1995 | 1,712,251 | ➤ Sign Up |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | 7,538,133*PED | ➤ Sign Up |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-003 | Jun 4, 1998 | 5,705,517*PED | ➤ Sign Up |
| Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | 5,196,444*PED | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ANI PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 4 mg, 8 mg, 16 mg and 32 mg | ➤ Subscribe | 2006-12-22 |
| ➤ Subscribe | Tablets | 32 mg/25 mg | ➤ Subscribe | 2009-03-06 |
| ➤ Subscribe | Tablets | 16 mg/12.5 mg and 32 mg/12.5 mg | ➤ Subscribe | 2008-06-25 |
International Patents for Ani Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2002330211 | ➤ Sign Up |
| European Patent Office | 1432411 | ➤ Sign Up |
| Canada | 2462637 | ➤ Sign Up |
| Japan | 2005508922 | ➤ Sign Up |
| Norway | 335070 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Ani Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0016 | Belgium | ➤ Sign Up | PRODUCT NAME: CANDESARTAN CILEXETIL; NAT. REGISTRATION NO/DATE: 212 IS 236 F3 19980119; FIRST REGISTRATION: GB PL 15661/0001 19970429 |
| C0040 | France | ➤ Sign Up | PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402 |
| 70044 | Netherlands | ➤ Sign Up | PRODUCT NAME: CANDESARTAN, DESGENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF VAN DE 1-(CYCLOHEXYLOXYCARBONYLOXY) ETHYLESTE R, IN HET BIJZONDER CILEXETILI CANDESARTANAS, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: RVG 21703 - RVG 21706 19971013; FIRST REGISTRATION: GB PL 15661/0001 - PL 15661/0004 19970429 |
| C0025 | Belgium | ➤ Sign Up | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
| C0012 | France | ➤ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
